Journal List > Urogenit Tract Infect > v.11(1) > 1084198

Lee, Kim, Ryu, Kim, Yangy, Lee, and Jung: Clinical Data of Urine Culture and Antimicrobial Sensitivity Tests according to the Voiding Method over 15 Years in Patients with Spinal Cord Injury

Abstract

Purpose

To analyze the results of urine cultures and antimicrobial sensitivity tests according to the voiding methods in patients with spinal cord injury (SCI) over a 15-year period.

Materials and Methods

A total of 1,579 urine culture samples, obtained from January 2000 to December 2014, for 73 SCI patients were analyzed according to the voiding method. We analyzed the following: positive urine culture rate, colony counts, isolated number of organism, major organisms, and antimicrobial sensitivity tests. The voiding methods were categorized into four methods: clean intermittent catheterization (CIC), suprapubic catheterization (SPC), urethral Foley catheter, and spontaneous voiding (SV).

Results

Among the 1,579 urine samples, 1,250 (79.2%) were positive. The CIC group showed the lowest rate of bacteriuria (p<0.001), colony counts (p<0.001), and polymicrobial infection (p<0.001). Causative organisms were mostly gram-negative bacteria (86.7%). Pseudomonas aeruginosa (22.7%) was most common pathogen followed by Escherichia coli (22.3%), Klebsiella species (9.5%), Providencia species (4.4%), and Serratia marcescens (4.2%). Major pathogens and antimicrobial sensitivity tests were different according to the voiding method.

Conclusions

CIC is the best voiding method to reduce urinary tract infection (UTI) in SCI patients. To treat UTI in in SCI patients, empirical antibiotics can be chosen according to the voiding method based on the reference of our study prior to the availability of antimicrobial sensitivity results.

References

1. So JG, Oh DJ, Lim YS, Park WH, Shim HB. Urologic complications and management in 337 spinal cord injured patients. Korean J Urol. 1997; 38:1075–80.
2. de Groat WC. Mechanisms underlying the recovery of lower urinary tract function following spinal cord injury. Paraplegia. 1995; 33:493–505.
crossref
3. Biering-Sorensen F, Bagi P, Hoiby N. Urinary tract infections in patients with spinal cord lesions: treatment and prevention. Drugs. 2001; 61:1275–87.
4. Dewire DM, Owens RS, Anderson GA, Gottlieb MS, Lepor H. A comparison of the urological complications associated with longterm management of quadriplegics with and without chronic indwelling urinary catheters. J Urol. 1992; 147:1069–71.
crossref
5. Hinkel A, Finke W, Botel U, Gatermann SG, Pannek J. Increasing resistance against antibiotics in bacteria isolated from the lower urinary tract of an outpatient population of spinal cord injury patients. Urol Int. 2004; 73:143–8.
crossref
6. Ryu KH, Kim YB, Yang SO, Lee JK, Jung TY. Results of urine culture and antimicrobial sensitivity tests according to the voiding method over 10 years in patients with spinal cord injury. Korean J Urol. 2011; 52:345–9.
crossref
7. Siroky MB. Pathogenesis of bacteriuria and infection in the spinal cord injured patient. Am J Med. 2002; 113(Suppl 1A)::S67–79.
crossref
8. The prevention and management of urinary tract infections among people with spinal cord injuries. National Institute on Disability and Rehabilitation Research Consensus Statement. January 27–29, 1992. J Am Paraplegia Soc. 1992; 15:194–204.
9. Dedeic-Ljubovic A, Hukic M. Catheter-related urinary tract infection in patients suffering from spinal cord injuries. Bosn J Basic Med Sci. 2009; 9:2–9.
10. Consortium for Spinal Cord Medicine. Bladder management for adults with spinal cord injury: a clinical practice guideline for healthcare providers. J Spinal Cord Med. 2006; 29:527–73.
11. Abrams P, Agarwal M, Drake M, El-Masri W, Fulford S, Reid S, et al. A proposed guideline for the urological management of patients with spinal cord injury. BJU Int. 2008; 101:989–94.
crossref
12. Stohrer M, Blok B, Castro-Diaz D, Chartier-Kastler E, Del Popolo G, Kramer G, et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol. 2009; 56:81–8.
13. Weld KJ, Dmochowski RR. Effect of bladder management on urological complications in spinal cord injured patients. J Urol. 2000; 163:768–72.
crossref
14. Gallien P, Nicolas B, Robineau S, Le Bot MP, Durufle A, Brissot R. Influence of urinary management on urologic complications in a cohort of spinal cord injury patients. Arch Phys Med Rehabil. 1998; 79:1206–9.
crossref
15. Cameron AP, Wallner LP, Tate DG, Sarma AV, Rodriguez GM, Clemens JQ. Bladder management after spinal cord injury in the United States 1972 to 2005. J Urol. 2010; 184:213–7.
crossref
16. Esclarin De Ruz A, Garcia Leoni E, Herruzo Cabrera R. Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury. J Urol. 2000; 164:1285–9.
17. West DA, Cummings JM, Longo WE, Virgo KS, Johnson FE, Parra RO. Role of chronic catheterization in the development of bladder cancer in patients with spinal cord injury. Urology. 1999; 53:292–7.
crossref
18. Groah SL, Weitzenkamp DA, Lammertse DP, Whiteneck GG, Lezotte DC, Hamman RF. Excess risk of bladder cancer in spinal cord injury: evidence for an association between indwelling catheter use and bladder cancer. Arch Phys Med Rehabil. 2002; 83:346–51.
crossref
19. Ko YH, Oh JS, Cho DY, Bea JH, Koh SK. Changes of causative organisms and antimicrobial sensitivity of urinary tract infection between 1979 and 2001. Korean J Urol. 2003; 44:342–50.
20. Song HJ, Kim SJ. A study of antimicrobial sensitivity to the causative organism of urinary tract infection. Korean J Urol. 2005; 46:68–73.
21. Ryu KH, Kim MK, Jeong YB. A recent study on the antimicrobial sensitivity of the organisms that cause urinary tract infection. Korean J Urol. 2007; 48:638–45.
crossref
22. Warren JW. Catheter-associated urinary tract infections. Int J Antimicrob Agents. 2001; 17:299–303.
crossref
23. Penders J, Huylenbroeck AA, Everaert K, Van Laere M, Verschraegen GL. Urinary infections in patients with spinal cord injury Spinal Cord. 2003; 41:549–52.
24. Mobley HL, Warren JW. Urease-positive bacteriuria and obstruction of longterm urinary catheters. J Clin Microbiol. 1987; 25:2216–7.
crossref
25. Hernandez Gonzalez E, Zamora Perez F, Martinez Arroyo M, Valdez Fernandez M, Alberti Amador E. [Epidemiologic, clinical and microbiological characteristics of nosocomial urinary infection in the spinal cord lesioned patient]. Actas Urol Esp. 2007; 31:764–70.
crossref

Table 1.
Positive urine cultures according to voiding method
Voiding method Sterile cultures Positive cultures Total p-valuea)
Clean intermittent catheterization 146 (27.6) 383 (72.4) 529 (100) <0.001
Suprapubic catheterization 82 (14.8) 473 (85.2) 555 (100)  
Urethral Foley catheter 64 (19.9) 258 (80.1) 322 (100)  
Spontaneous voiding 37 (21.4) 136 (78.6) 173 (100)  

Values are presented as number (%).

a) Analyzed by chi-square test.

Table 2.
Colony counts of the positive urine cultures
Voiding method Colony counts (CFU/ml) p-valuea)
103≤ <104 104≤ <105 105≤ <106 ≥106 Total (%)
Clean intermittent catheterization 2 (0.5) 32 (8.4) 182 (47.5) 167 (43.6) 383 (100) <0.001
Suprapubic catheterization 0 34 (7.2) 192 (40.6) 247 (52.2) 473 (100)  
Urethral Foley catheter 0 25 (9.7) 118 (45.9) 115 (44.4) 258 (100)  
Spontaneous voiding 0 6 (4.4) 58 (43.0) 72 (52.6) 136 (100)  

Values are presented as number (%).

Values are presented as number (%). CFU: colony-forming units.

a) Analyzed by chi-square test.

Table 3.
Isolates of urine cultures according to voiding method
Voiding method Isolated number p-valuea)
1 2 3 Total
Clean intermittent catheterization 326 (85.1) 54 (14.1) 3 (0.8) 383 (100) <0.001
Suprapubic catheterization 284 (60.0) 186 (39.3) 3 (0.6) 473 (100)  
Urethral Foley catheter 188 (72.9) 68 (26.4) 2 (0.8) 258 (100)  
Spontaneous voiding 106 (77.9) 27 (19.9) 3 (2.2) 136 (100)  

Values are presented as number (%).

a) Analyzed by chi-square test.

Table 4.
Major causative organisms (top 1–10)
Causative organism Voiding method Total
CIC SPC UF SV
Pseudomonas aeruginosa 45 (10.2) 210 (31.6) 69 (20.9) 41 (24.3) 365 (22.7)
Escherichia coli 146 (33.0) 90 (13.5) 81 (24.5) 42 (24.9) 359 (22.3)
Klebsiella species 71 (16.0) 45 (6.8) 23 (7.0) 14 (8.3) 153 (9.5)
Streptococcus species 36 (8.1) 60 (9.0) 15 (4.5) 14 (8.3) 125 (7.8)
Providencia species 14 (3.2) 40 (6.0) 7 (2.1) 10 (5.9) 71 (4.4)
Serratia marcescens 21 (4.7) 27 (4.1) 15 (4.5) 4 (2.4) 67 (4.2)
Citrobacter species 25 (5.6) 23 (3.5) 11 (3.3) 5 (3.0) 64 (4.0)
Staphylococcus species 24 (5.4) 16 (2.4) 6 (1.8) 10 (5.9) 56 (3.5)
Staphylococcus species 24 (5.4) 16 (2.4) 6 (1.8) 10 (5.9) 56 (3.5)
Acinetobacter species 13 (2.9) 21 (3.2) 13 (3.9) 8 (4.7) 55 (3.4)
Morganella morganii 10 (2.3) 24 (3.7) 19 (5.8) 2 (1.2) 55 (3.4)
Proteus species 7 (1.6) 22 (3.3) 10 (3.0) 6 (3.6) 45 (2.8)

Values are presented as number (%).

CIC: clean intermittent catheterization, SPC: suprapubic catheterization, UF: urethral Foley catheter, SV: spontaneous voiding.

Table 5.
Results of antimicrobial sensitivity tests according to voiding method
Antibiotics Voiding method
CIC SPC UF SV
Penicillin 51.4 66.4 36.6 21.9
Ampicillin 10.4 9.8 7.4 12.4
Augmentin 52.3 43.8 44.0 44.6
Cefazolin 46.5 33.5 35.5 41.3
Cefoxitin 61.8 58.3 55.1 60.5
Cefotetan 59.3 39.0 69.7 72.7
Cefuroxime 32.5 18.4 30.8 47.1
Ceftazidime 64.9 60.6 60.6 76.7
Ceftriaxone 47.8 32.9 43.2 49.0
Cefepime 82.7 71.0 64.8 75.6
Ofloxacin 65.1 53.4 92.9 75.0
Ciprofloxacin 37.2 41.1 35.5 36.7
Levofloxacin 43.9 33.9 32.4 32.3
Gentamicin 59.8 56.4 50.1 46.2
Tobramycin 64.4 54.6 61.1 51.9
Amikacin 89.5 76.3 76.1 74.2
Piperacillin 35.7 47.8 33.2 42.8
Piperacillin/tazobactam 76.9 66.5 61.1 81.3
Imipenem 94.9 92.5 78.2 94.8
Meropenem 95.0 92.3 76.0 95.7
Ertapenem 100 97.9 98.1 100
Teicoplanin 100 93.5 63.6 100
Vancomycin 100 96.8 69.2 100
Trimethoprim-sulfamethoxazole 50.6 44.0 43.9 43.0
Tetracycline 30.2 31.6 42.7 32.7

Values are presented as a percentage.

CIC: clean intermittent catheterization, SPC: suprapubic catheterization, UF: urethral Foley catheter, SV: spontaneous voiding.

TOOLS
Similar articles